Remove 2007 Remove Food and Drug Administration Remove Training
article thumbnail

Innovating allergy drug delivery with a needle-free alternative

European Pharmaceutical Review

This decision was granted a couple of weeks following approval by the US and Drug Administration (FDA). Approximately 40 million people in the US experience Type I allergic reactions due to food, venom or insect stings, 4 and the numbers are similar in Europe. 2007; 2(1):5-11. She holds an MBA from McGill University.

article thumbnail

The Future for Biotesting

Pharmaceutical Technology

Firstly, there is a comprehensive toxicological service for human and veterinary pharmaceuticals and biopharmaceuticals, food additives, chemicals and agrochemicals. NC: A few projects focusing on influenza, which Biotest was involved with, concluded in 2007. Can you reveal the results of these?

article thumbnail

Innovations & Challenges in Brain Health

PM360

They are difficult to diagnose early in a disease, the regulatory endpoints are often unprecedented and challenging, and many drugs struggle to get into the brain. The downside is that it also keeps most potential drug treatments from reaching the brain. Not surprisingly, several companies have been in and out of brain health diseases.